Table 1.
Baseline characteristics of randomized participants.
| Characteristic | Group |
P value | |||
|---|---|---|---|---|---|
| Acupuncture | Control | Cupping | |||
| Age (years) (Mean ± SD) |
52.74±12.72 | 57.90±12.15 | 54.68±13.79 | 0.187† | |
| Sex N (%) |
Male | 17 (40.47) | 14 (33.33) | 16 (36.36) | 0.793* |
| Female | 25 (59.53) | 28 (66.67) | 28 (63.64) | ||
| Patients with coexisting disorders N (%) |
Diabetes mellitus | 13 (30.95) | 15 (35.71) | 10 (22.72) | 0.410* |
| Hypertension | 15 (35.71) | 17 (40.47) | 12 (27.27) | 0.425* | |
| Hypothyroid | 5 (11.90) | 1 (2.38) | 2 (4.54) | 0.167* | |
| Anemia | 2 (4.76) | 0 (0.0) | 3 (6.81) | 0.249* | |
| Asthma | 0 (0.0) | 0 (0.0) | 0 (0.0) | - | |
| Cancer | 0 (0.0) | 0 (0.0) | 0 (0.0) | - | |
| Chronic kidney disease | 0 (0.0) | 0 (0.0) | 0 (0.0) | - | |
| Chronic obstructive pulmonary disease | 0 (0.0) | 0 (0.0) | 0 (0.0) | - | |
| Duration of symptoms before admission1 (days) (Mean ± SD) |
5.29±3.71 | 7.02±3.50 | 7.26±3.64 | 0.026† | |
| Computed tomography (CT) scan findings N (%) |
Mild | 18 (31.0) | 22 (37.9) | 18 (31.0) | 0.524* |
| Moderate | 16 (32.7) | 17 (34.7) | 16 (32.7) | 0.926* | |
| Severe | 4 (28.6) | 4 (28.6) | 6 (42.9) | 0.778* | |
| Non typical COVID-19 | 3 (34.9) | 1 (14.3) | 3 (42.9) | 0.561* | |
*Chi-Square Tests; †ANOVA test; 1: data is represented by mean ± standard deviation or frequency (percentage).